Siddique, M.H.; Bukhari, S.; Khan, I.U.; Essa, A.; Ali, Z.; Sabir, U.; Ayoub, O.; Saadia, H.; Yaseen, M.; Sultan, A.;
et al. In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation. Pharmaceuticals 2023, 16, 1742.
https://doi.org/10.3390/ph16121742
AMA Style
Siddique MH, Bukhari S, Khan IU, Essa A, Ali Z, Sabir U, Ayoub O, Saadia H, Yaseen M, Sultan A,
et al. In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation. Pharmaceuticals. 2023; 16(12):1742.
https://doi.org/10.3390/ph16121742
Chicago/Turabian Style
Siddique, Muhammad Hamid, Sidra Bukhari, Inam Ullah Khan, Asiya Essa, Zain Ali, Usama Sabir, Omiya Ayoub, Haleema Saadia, Muhammad Yaseen, Aneesa Sultan,
and et al. 2023. "In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation" Pharmaceuticals 16, no. 12: 1742.
https://doi.org/10.3390/ph16121742
APA Style
Siddique, M. H., Bukhari, S., Khan, I. U., Essa, A., Ali, Z., Sabir, U., Ayoub, O., Saadia, H., Yaseen, M., Sultan, A., Murtaza, I., Kerr, P. G., Bhat, M. A., & Anees, M.
(2023). In Silico, In Vitro, and In Vivo Evaluation of Caffeine-Coated Nanoparticles as a Promising Therapeutic Avenue for AML through NF-Kappa B and TRAIL Pathways Modulation. Pharmaceuticals, 16(12), 1742.
https://doi.org/10.3390/ph16121742
